ArticlePloS one2025

The effect of IL-1β inhibitor canakinumab (Ilaris®) on IL-6 production in human skeletal muscle cells.

Anna Cordeiro-Santanach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.